Rob Ball – Keynote Panelist at OMTEC 2019
Rob Ball, CEO of Genesis Innovation Group will be a Keynote Panelist at OMTEC 2019.
News
Shoulder Innovations Announces Publication of Long Term Data for InSet Glenoid
HOLLAND, Mich., April 18th, 2019—Genesis Innovation Group’s Shoulder Innovations (SI) is focused on human centered design.
cultivate(MD) Announces Investment Into HAPPE Spine
HOLLAND, Mich., April 11, 2019 — Genesis Innovation Group and their cultivate(MD) Capital Fund I and cultivate(MD) Capital Fund II, LP, funds focused on investments into early stage healthcare companies …
cultivate(MD) Announces Investment Into Magnesium Development Company
HOLLAND, Mich., March 11, 2019 /PRNewswire/ — Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces its …
cultivate(MD) Announces Investment Into Embody, Inc.
HOLLAND, Mich., March 4th, 2019– Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces its investment into …
ASAP Meeting Workshop
Genesis will be hosting a special Workshop at the 2019 ASAP Meeting.
VC fund invests in medical software startup – Grand Rapids Business Journal
A venture capital fund in the region has invested in a medical startup on the state’s east side.
cultivate(MD) Announces Investment Into SpinTech
HOLLAND, Mich., December 3rd, 2018—Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments in early stage healthcare companies with innovative technologies, announces its investment into SpinTech.
VC fund invests in medical device startup – Grand Rapids Business Journal
A venture capital fund in the region focused on early stage health care companies with innovative technologies has made a new out-of-state investment.
cultivate(MD) Announces Investment Into Medical Ingenuities, LLC.
HOLLAND, Mich., November 20th, 2018—Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments in early stage healthcare companies with innovative technologies, announces its investment into Medical …